MarketCapTrends
FENC
Fennec Pharmaceuticals Inc. (FENC)
NASDAQ · Healthcare

Fennec Pharmaceuticals Inc. Total Liabilities 2011–2025

Fennec Pharmaceuticals Inc. annual/quarterly total liabilities history from 2011 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • Fennec Pharmaceuticals Inc. total liabilities for the quarter ending December 31, 2025 were 35.1M, a 30.97% decrease year-over-year.
  • Fennec Pharmaceuticals Inc. total liabilities for 2025 were 35.1M, a 30.97% decrease from 2024.
  • Fennec Pharmaceuticals Inc. total liabilities for 2024 were 50.8M, a 32.04% increase from 2023.
  • Fennec Pharmaceuticals Inc. total liabilities for 2023 were 38.5M, a 30.43% increase from 2022.
  • Fennec Pharmaceuticals Inc. total liabilities for 2022 were 29.5M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Fennec Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $)
2025$35
2024$51
2023$38
2022$30
2020$2
2019$2
2018$2
2017$2
2016$0
2015$0
2014$2
2013$3
2012$7
2011$5
Fennec Pharmaceuticals Inc. Quarterly Total Liabilities (Millions of US $)
2025-12-31$35
2024-12-31$51
2023-12-31$38
2022-12-31$30
2020-12-31$2
2019-12-31$2
2018-12-31$2
2017-12-31$2
2016-12-31$0
2015-12-31$0
2014-12-31$2
2013-12-31$3
2012-12-31$7
2011-12-31$5

Fennec Pharmaceuticals Inc. Total Liabilities — FAQ

Fennec Pharmaceuticals Inc. (FENC) total liabilities over the last 14 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see FENC's total liabilities history?

The chart and table above show Fennec Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.